Michel Garenne: Difference between revisions
m formattings |
WikiModEn2 (talk | contribs) Add link in SEEALSO section. |
||
| (9 intermediate revisions by 2 users not shown) | |||
| Line 11: | Line 11: | ||
== No net effect of circumcision on HIV == | == No net effect of circumcision on HIV == | ||
In 2022, Garenne investigated the complex relationships between [[circumcision]] and [[HIV]] prevalence in Lesotho and found no net effect of [[circumcision]] on [[HIV]]. The study (see below) questions the amount of effort and money spent on [[VMMC]] in Lesotho. | In 2022, Garenne investigated the complex relationships between [[circumcision]] and [[HIV]] prevalence in Lesotho and found no net effect of [[circumcision]] on [[HIV]]. The study (see below) questions the amount of effort and money spent on [[VMMC]] in Lesotho. | ||
== Population-based studies == | |||
New population-based studies (2021) confirm Garenne's findings. | |||
{{Population-based studies}} | |||
{{PUB}} | {{PUB}} | ||
* {{REFjournal | |||
|last=Garenne | |||
|first=Michel | |||
|init=M | |||
|author-Michel Garenne | |||
|etal=no | |||
|title=Age-incidence and prevalence of HIV among intact and circumcised men: an analysis of PHIA surveys in Southern Africa | |||
|trans-title= | |||
|language= | |||
|journal=J Biosoc Sci | |||
|location= | |||
|date=2022-10-26 | |||
|season= | |||
|volume= | |||
|issue= | |||
|article= | |||
|page= | |||
|pages=1-13 | |||
|url=https://www.cambridge.org/core/journals/journal-of-biosocial-science/article/abs/ageincidence-and-prevalence-of-hiv-among-intact-and-circumcised-men-an-analysis-of-phia-surveys-in-southern-africa/CAA7E7BD5A9844F41C6B7CC3573B9E50 | |||
|archived= | |||
|quote= | |||
|pubmedID=36286328 | |||
|pubmedCID= | |||
|DOI=10.1017/S0021932022000414 | |||
|accessdate=2022-10-27 | |||
}} | |||
* {{REFjournal | * {{REFjournal | ||
|last=Garenne | |last=Garenne | ||
| Line 27: | Line 58: | ||
|pubmedID=35373731 | |pubmedID=35373731 | ||
|accessdate=2022-04-12 | |accessdate=2022-04-12 | ||
}} | |||
* {{REFjournal | |||
|last=Mapanga | |||
|init=W | |||
|last2=Masukume | |||
|init2=G | |||
|last3=Garenne | |||
|init3=M | |||
|author3-link=Michel Garenne | |||
|date=2021-11-01 | |||
|title=Impact of excluded studies on medical male circumcision and HIV risk compensation (letter) | |||
|journal=Lancet Global Health | |||
|volume=9 | |||
|issue=11 | |||
|page=E1505 | |||
|DOI=10.1016/S2214-109X(21)00437-X | |||
}} | }} | ||
* {{REFjournal | * {{REFjournal | ||
| Line 44: | Line 91: | ||
|DOI=10.1017/S0021932019000634 | |DOI=10.1017/S0021932019000634 | ||
|accessdate=2022-04-12 | |accessdate=2022-04-12 | ||
}} | }} | ||
* {{REFbook | |||
|last=Garenne | |||
|first=Michel | |||
|init=M | |||
|author-link=Michel Garenne | |||
|date=2017 | |||
|chapter=La circoncision dans le monde gréco-romain : Aspects historiques, philosophiques et légaux | |||
|title=Des limites à la volonté de puissance ? (Essais de Philosophie Pénale et de Criminologie) | |||
|url=https://www.documentation.ird.fr/hor/fdi:010072566 | |||
|editors=Philippe Conte & Stamatios Tzitzis | |||
|location=Paris | |||
|publisher=Daloz | |||
|journal= | |||
|volume=12 | |||
|pages=7-22 | |||
|ISBN=978-2-247-16290-1 | |||
}} | |||
* {{REFbook | |||
|last=Garenne | |||
|init=M | |||
|author-link=Michel Garenne | |||
|last2=Giami | |||
|init2=A | |||
|last3=Perrey | |||
|init3=C | |||
|year=2013 | |||
|chapter=8: Male circumcision and HIV control in Africa: Questioning scientific evidence and decision making process | |||
|title=Global Health in Africa | |||
|editors=Tamara Giles-Vernick & James Webb | |||
|publisher=Ohio Press University | |||
}} | |||
* {{REFjournal | |||
|last=Garenne | |||
|init=M | |||
|author-link=Michel Garenne | |||
|date=2012 | |||
|title=La circoncision médicale masculine comme outil d’une politique sanitaire : le marketing de la science. (Commentaires sur un article de A. Giami, C. Perrey et al) | |||
|journal=Sciences Sociales et Santé | |||
|volume=30 | |||
|issue=1 | |||
|url=https://www.cairn.info/revue-sciences-sociales-et-sante-2012-1-page-39.htm | |||
|pages=39-46 | |||
}} | |||
* {{REFbook | |||
|last=Garenne | |||
|init=M | |||
|author-link=Michel Garenne | |||
|year=2010 | |||
|chapter=Mass campaigns of male circumcision for HIV control in Africa: Clinical efficacy, Population effectiveness, Political issues | |||
|editors=Denniston GC, Hodges FM, Milos MF | |||
|title=Genital Autonomy. Protecting Personal Choice | |||
|publisher=Springer | |||
|location=Dordrecht | |||
|pages=49-60 | |||
|DOI=10.1007/978-90-481-9446-9 | |||
}} | |||
* {{REFjournal | |||
|last=Garenne | |||
|init=M | |||
|author-link=Michel Garenne | |||
|date=2008 | |||
|title=Long-term population effect of male circumcision in generalized HIV epidemics in sub-Saharan Africa | |||
|journal=African Journal of AIDS Research | |||
|volume=7 | |||
|issue=1 | |||
|url=https://www.academia.edu/download/47300377/Long-term_population_effect_of_male_circ20160717-5943-17e4vyg.pdf | |||
|pages=1-8 | |||
}} | |||
* {{REFjournal | |||
|last=Garenne | |||
|init=M | |||
|author-link=Michel Garenne | |||
|date=2007-07-03 | |||
|title=Male circumcision as a public health policy: ethical challenges [e-letter for Rennie et al.] | |||
|journal=Journal of Medical Ethics | |||
|volume=33 | |||
|issue=6 | |||
|pages=357-61 | |||
}} | |||
* {{REFjournal | |||
|last=Garenne | |||
|init=M | |||
|author-link=Michel Garenne | |||
|date=2006 | |||
|title=Male circumcision and HIV control in Africa [Letter] | |||
|journal=PLoS Medicine | |||
|volume=3 | |||
|issue=1 | |||
|page=e78 | |||
}} | |||
{{SEEALSO}} | |||
* [[United States of America]] | |||
{{LINKS}} | {{LINKS}} | ||
* {{REFweb | * {{REFweb | ||
| Line 67: | Line 205: | ||
[[Category:Researcher]] | [[Category:Researcher]] | ||
[[Category:Author]] | |||
[[Category:France]] | [[Category:France]] | ||